Acurx Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Acurx Pharmaceuticals

16/03/2023 13:31

* Acurx Pharmaceuticals Inc  ACXP.OQ  reported a quarterly
adjusted loss of 28 cents​​ per share for the quarter ended in
December. The mean expectation of three analysts for the quarter
was for a loss of 35 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Acurx Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 28 cents​.
    * The mean earnings estimate of analysts had fallen by
about 12.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Acurx Pharmaceuticals Inc shares had fallen by 14.3% this
quarter.
    * The company reported a quarterly loss of $3.26 million.
    * Wall Street's median 12-month price target for Acurx
Pharmaceuticals Inc is $14.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 16 at 01:30 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.35          -0.28          Beat
 Sep. 30 2022      -0.28          -0.32          Missed
 Mar. 31 2022      -0.33          -0.26          Beat